• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[地西他滨增强白血病干细胞对异基因自然杀伤细胞介导杀伤的敏感性]

[Decitabine Enhances the Sensitivity of Leukemia Stem Cell to Allo-NK Cell-Mediated Killing].

作者信息

Li Qian, Wei Shan-Shan, Li Jin-Gao, Chen Shao-Xian, Chen Jing, Huang Hui-Ting, Peng Qi, Xia Ping-Fang, She Miao-Rong

机构信息

Department of Hematology, Guangdong People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou 510080, Guangdong Province, China.

Department of Hematology, Jingmen Municipal First People's Hospital, Jingmen 448000, Hubei Province, China.

出版信息

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):85-89. doi: 10.7534/j.issn.1009-2137.2017.01.014.

DOI:10.7534/j.issn.1009-2137.2017.01.014
PMID:28245380
Abstract

OBJECTIVE

To investigate the allo-NK cell-mediated killing effect enhanced by decitabine on leukemia stem cells(LSC) and the underlying mechanisms.

METHODS

LSC were separated from KG1a cells by using immunomagnetic beads. Allo-NK cells were isolated and purified from PBMC of healthy donors. Cytotoxicity of allo-NK cells against LSC were measured by LDH releasing assay. The apoptosis induced by allo-NK cells in LSC and the expressions of NKG2D ligands including MICA/B and ULBP1-3 on LSC were detected by flow cytometry.

RESULTS

The killing rate of allo-NK cells to LSC treated with 10 µmol/L decitabine for 24 hours was significant higher than that to LSC without treatment(60.52%±3.52% vs 22.08%±2.07%, 73.93%±2.33% vs 28. 99%±3.13%, 83.08%±1.32% vs 36.44%±2.40%, respectively)at the effector-target ratios of 5:1, 10:1, 20:1 (P<0.05). At the effector-target ratio of 10:1, decitabine significantly enhanced the apoptosis of LSC induced by allo-NK cells (7.84%±0.34% vs 3.33%±0.64%)(P<0.05). The expressions of NKG2D ligands(MICA/B,ULBP1,ULBP2,ULBP3) on LSC treated with decitabine 10 µmol/L for 24 hours were significantly increased (P<0.05).

CONCLUSION

Decitabine may enhance the allo-NK cell-mediated killing effects on LSC by up-regulation of the expressions of NKG2D ligands on LSC.

摘要

目的

探讨地西他滨增强同种异体自然杀伤(allo-NK)细胞对白血病干细胞(LSC)的杀伤作用及其潜在机制。

方法

采用免疫磁珠法从KG1a细胞中分离LSC。从健康供者外周血单个核细胞(PBMC)中分离并纯化allo-NK细胞。采用乳酸脱氢酶(LDH)释放法检测allo-NK细胞对LSC的细胞毒性。通过流式细胞术检测allo-NK细胞诱导LSC凋亡的情况以及LSC上NKG2D配体包括MICA/B和ULBP1-3的表达。

结果

在效应细胞与靶细胞比例为5:1、10:1、20:1时,用10 μmol/L地西他滨处理24小时的LSC,allo-NK细胞对其杀伤率显著高于未处理的LSC(分别为60.52%± 3.52%对22.08%±2.07%,73.93%±2.33%对28.99%±3.13%,83.08%±1.32%对36.44%±2.40%)(P<0.05)。在效应细胞与靶细胞比例为10:1时,地西他滨显著增强了allo-NK细胞诱导的LSC凋亡(7.84%±0.34%对3.33%±0.64%)(P<0.05)。用10 μmol/L地西他滨处理24小时的LSC上NKG2D配体(MICA/B、ULBP1、ULBP2、ULBP3)的表达显著增加(P<0.05)。

结论

地西他滨可能通过上调LSC上NKG2D配体的表达来增强allo-NK细胞对LSC的杀伤作用。

相似文献

1
[Decitabine Enhances the Sensitivity of Leukemia Stem Cell to Allo-NK Cell-Mediated Killing].[地西他滨增强白血病干细胞对异基因自然杀伤细胞介导杀伤的敏感性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):85-89. doi: 10.7534/j.issn.1009-2137.2017.01.014.
2
[Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].[多药耐药鼻咽癌细胞系CNE2/DDP中NKG2D配体的表达及其对自然杀伤细胞细胞毒性的影响]
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Jun;27(6):887-9.
3
[Matrine enhances the cytotoxic sensitivity of ABCG2high nasopharyngeal carcinoma cells to natural killer cells by inducing high expression of NKG2D receptor ligands].[苦参碱通过诱导NKG2D受体配体高表达增强ABCG2高表达鼻咽癌细胞对自然杀伤细胞的细胞毒性敏感性]
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Jul;29(7):1329-32.
4
Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition.通过去甲基化剂增加TIMP3表达可减少急性髓系白血病中可溶性MICA、MICB和ULBP2的脱落,促进自然杀伤细胞介导的免疫识别。
Oncotarget. 2017 May 9;8(19):31959-31976. doi: 10.18632/oncotarget.16657.
5
Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.地西他滨在增殖条件下对自然杀伤细胞活力、表型和功能具有双相作用。
Mol Immunol. 2013 Jul;54(3-4):296-301. doi: 10.1016/j.molimm.2012.12.012. Epub 2013 Jan 16.
6
[Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells].[不同发育阶段树突状细胞上NKG2D配体的表达及其对NK细胞细胞毒性的影响]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2008 Apr;24(4):341-3, 347.
7
Induction of NKG2D ligands and increased sensitivity of tumor cells to NK cell-mediated cytotoxicity by hematoporphyrin-based photodynamic therapy.基于血卟啉的光动力疗法诱导 NKG2D 配体的产生,并增加肿瘤细胞对 NK 细胞介导的细胞毒性的敏感性。
Immunol Invest. 2011;40(4):367-82. doi: 10.3109/08820139.2010.551435. Epub 2011 Feb 11.
8
[NKG2D-mediated natural killer cell cytotoxicity against myeloid leukemia cells OUN-1].[NKG2D介导的自然杀伤细胞对髓系白血病细胞OUN-1的细胞毒性作用]
Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):444-7.
9
Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity.罗米地辛上调急性淋巴细胞白血病和非霍奇金淋巴瘤细胞中NKG2D配体,并增强体外和体内自然杀伤细胞的细胞毒性。
Cytotherapy. 2014 Oct;16(10):1431-40. doi: 10.1016/j.jcyt.2014.03.008. Epub 2014 May 20.
10
[Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].[人鼻咽癌细胞系对自然杀伤细胞的免疫编辑:杀伤细胞免疫球蛋白样受体(KIRs)和自然杀伤细胞2D受体(NKG2D)表达改变导致自然杀伤细胞介导的细胞溶解作用降低]
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Mar;27(3):247-9.

引用本文的文献

1
Concentration-Dependent Decitabine Effects on Primary NK Cells Viability, Phenotype, and Function in the Absence of Obvious NK Cells Proliferation-Original Article.在无明显自然杀伤细胞增殖的情况下,浓度依赖性地西他滨对原代自然杀伤细胞活力、表型及功能的影响——原创文章
Front Pharmacol. 2021 Oct 25;12:755662. doi: 10.3389/fphar.2021.755662. eCollection 2021.
2
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer.靶向表观遗传修饰的药物及针对结直肠癌的合理治疗策略
Front Pharmacol. 2019 Jun 6;10:588. doi: 10.3389/fphar.2019.00588. eCollection 2019.